Replies to post #69919 on Biotech Values

[DewDiligence]

>ITMN – didn't change its time line for the following phase-2b trial that is still expected to begin in 1H09.<

This is why companies like such vague timeframes as “1H09” — the timeline can slip without having a timeline slip.